Gastrotene

by Zycal Bioceuticals Healthcare · capsule · 60 capsules

  • Off the market since March 2023 (NIH)
  • DSLD label 247887
  • Serving 1 to 3 capsules; amounts per 1 capsule

Gastrotene by Zycal Bioceuticals Healthcare lists 2 ingredients, 2 with an amount per serving of 1 capsule, such as 275 mg of L-glutamine and 100 mg of slippery elm extract. Its current label entered the NIH Dietary Supplement Label Database on April 22, 2021.

What is in Gastrotene?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Gastrotene: Supplement Facts rows against the market (DSLD label 247887, January 2026 release)
IngredientAmount% DVAmong products listing it
L-Glutamine275 mgGlutamine in Gastrotene against 1,850 products0.275 g per serving; the middle half of products list 0.356 g to 3 g, the median 1 g.0.275 g

77% of 1,850 products listing glutamine give more (median 1 g).

2-Beta Coxatene135 mg
Slippery Elm extract100 mgSlippery Elm in Gastrotene against 232 products100 mg per serving; the middle half of products list 50 mg to 300 mg, the median 150 mg.100 mg

59% of 232 products listing slippery elm give more (median 150 mg).

Source: NIH ODS Dietary Supplement Label Database, label 247887 (entered April 22, 2021), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

The products whose ingredient lists overlap most with Gastrotene's, rare ingredients counting for more.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested dosage: As a dietary supplement, take one (1) to three (3) capsules per day.
Warnings
Warning: Consult a physician before using if pregnant, nursing or on medication.
Do not use if inner seal is missing or broken.
Keep out of the reach of children.
Storage
Store in a cool, dry place.

Source: label statements in DSLD label 247887.

What else is on the label?

Other ingredients: Gelatin Capsules, Microcrystalline Cellulose.

How many labels does Gastrotene have?

2 labels are on file under this name since January 7, 2019: other sizes, label designs and reformulations. The current one leads this page.

  1. Label 247887 (current) Entered April 22, 2021 · off the market March 23, 2023 · 60 capsules
  2. Label 185094 Entered January 7, 2019 · off the market March 23, 2023 · 60 capsules

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names ZyCal Bioceuticals Healthcare Co. (distributor), Toms River, NJ. All Zycal Bioceuticals Healthcare products.

Where next?